With its open innovation program Grants4Traits, Bayer now supports novel ideas that will lead to innovative commercial seed products. Researchers at universities, other scientific institutions, or start-up companies all over the world working on traits that will help achieve higher yield, quality and safety in crops are encouraged to participate in Bayer’s new program.
Keep updated with our latest news.
A growing and aging world population, limited natural resources and the impact of climate change make it important to improve crop yield, stress tolerance and nutritional value while minimizing environmental impact.
We thought we had a mature understanding of our business model – and emerged with a model that is actually viable for a startup company.
I expect immunoncology to become established as an integral part of cancer treatment over the next few years and to offer real prospects.
Startups whose work is related to Bayer’s pharmaceutical R&D focus are offered rental office and lab space on the company’s campus in Berlin. Working side by side has inspired fruitful scientific discussion.
Our scientific successes are intended to help improve people’s lives.
At the same time, our innovations form the basis for sustainable and profitable business activity.